These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34069490)

  • 1. Essential Oils,
    Lahmar A; Mathey A; Aires V; Elgueder D; Vejux A; Khlifi R; Sioud F; Chekir-Ghedira L; Delmas D
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin.
    Chang CC; Huang LH; Chiang W; Hsia SM
    Phytomedicine; 2018 Aug; 47():69-80. PubMed ID: 30166110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effect of pheophorbide a-mediated photodynamic therapy and its synergistic effect with doxorubicin on multiple drug-resistant uterine sarcoma cell MES-SA/Dx5.
    Cheung KK; Chan JY; Fung KP
    Drug Chem Toxicol; 2013 Oct; 36(4):474-83. PubMed ID: 23560455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
    Hua J; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
    Lin ST; May EW; Chang JF; Hu RY; Wang LH; Chan HL
    Cell Mol Life Sci; 2015 Jun; 72(12):2395-409. PubMed ID: 25596698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells.
    Hung TH; Chen CM; Tseng CP; Shen CJ; Wang HL; Choo KB; Chong KY
    Int J Biochem Cell Biol; 2014 Aug; 53():55-65. PubMed ID: 24814288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
    Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
    Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.
    Lee SY; Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Jung MH; Kim SH; Lee EO; Ahn KS; Ahn KS; Kim SH
    Environ Toxicol; 2011 Aug; 26(4):424-31. PubMed ID: 20196146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol, furosemide and a phytotherapeutic agent (Bazoton uno) reverse P-glycoprotein-mediated doxorubicin resistance in human uterine sarcoma MES-SA/Dx5 cells: a novel therapeutic perspective.
    Angelini A; Centurione MA; Di Pietro R; Centurione L
    J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):991-997. PubMed ID: 31162035
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
    Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
    J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA/Dx5 multidrug-resistant uterine sarcoma cell lines.
    Pósa SP; Dargó G; Nagy S; Kisszékelyi P; Garádi Z; Hámori L; Szakács G; Kupai J; Tóth S
    Bioorg Med Chem; 2022 Aug; 67():116855. PubMed ID: 35640378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumvention of resistance to photodynamic therapy in doxorubicin-resistant sarcoma by photochemical internalization of gelonin.
    Olsen CE; Berg K; Selbo PK; Weyergang A
    Free Radic Biol Med; 2013 Dec; 65():1300-1309. PubMed ID: 24076428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5.
    Shibaki R; Kakikawa M
    Electromagn Biol Med; 2022 Jul; 41(3):343-351. PubMed ID: 35793396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells.
    Angelini A; Di Pietro R; Centurione L; Castellani ML; Conti P; Porreca E; Cuccurullo F
    J Biol Regul Homeost Agents; 2012; 26(3):495-504. PubMed ID: 23034269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells.
    Wang E; Lee MD; Dunn KW
    J Cell Physiol; 2000 Aug; 184(2):263-74. PubMed ID: 10867652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells.
    Lin ST; Chou HC; Chang SJ; Chen YW; Lyu PC; Wang WC; Chang MD; Chan HL
    J Proteomics; 2012 Oct; 75(18):5822-47. PubMed ID: 22889595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening.
    Wesolowska O; Paprocka M; Kozlak J; Motohashi N; Dus D; Michalak K
    Anticancer Res; 2005; 25(1A):383-9. PubMed ID: 15816562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
    Angelini A; Ciofani G; Conti P
    J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
    Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C
    J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.